Carlos A Zarate

13PUBLICATIONS
37CO-AUTHORS
Biologically active moleculesClinical psychologyTraditional Chinese medicine and treatmentsPharmacogenomicsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 07, 2026
The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression: A Phase IIa Proof-of-Concept Clinical Trial.

|Jan 22, 2026
A preliminary proof-of-concept trial on the effects of ketamine on fatigue: a randomized crossover trial.

Taichi Goto, Joy D Kreskow, Alexander L R Ross

|Dec 31, 2024
Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials.

Johan Saelens, Anna Gramser, Victoria Watzal

|Jul 12, 2024
Esketamine in depression: putative biomarkers from clinical research.

Jenessa N Johnston, Carlos A Zarate, Mark D Kvarta

|Jun 14, 2024
Potential association between suicide risk, aggression, impulsivity, and the somatosensory system.

Yoojin Lee, Jessica R Gilbert, Laura R Waldman

|Nov 24, 2023
Clinical, behavioral, and electrophysiological profiles along a continuum of suicide risk: evidence from an implicit association task.

Steven J Lamontagne, Jessica R Gilbert, Paloma K Zabala

Pageof 3

Frequent Collaborators

2 joint publications

Ioline D Henter

2 joint publications

Lawrence T Park

2 joint publications

Elizabeth D Ballard

2 joint publications

Mark D Kvarta